Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by ForexWhaleon Sep 06, 2018 12:00pm
177 Views
Post# 28572495

Timing of the news

Timing of the news
To me this is a bit awkward that when the Rodman conference is almost over, they release this news as if someone will make arragements last minute to arrange 1-1 meetings. I know they mentioned about Rodman conf before as well on 29th but this news release should have been earlier or together with the same NR.

I think the deal is already in negotiation and this relese was to boost the stock price for better deal with the potential partner. Something is going on behind he scenes. Phase 1 results might even be better than what iCo expected so could be 2-3 parties interested.

<< Previous
Bullboard Posts
Next >>